Havlickova 648 a.s. 13D and 13G filings for Cadrenal Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 1:05 pm Purchase |
2024-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Havlickova 648 a.s. | 78,291 4.390% |
11,959 (+18.03%) |
Filing |
| 2024-10-04 4:15 pm Purchase |
2024-09-20 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Havlickova 648 a.s. | 66,332 6.200% |
66,332 (New Position) |
Filing |